+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Lipid Test Kits Market - Global Forecast 2026-2032- Product Image
Blood Lipid Test Kits Market - Global Forecast 2026-2032- Product Image
Sale

Blood Lipid Test Kits Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122597
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Lipid Test Kits Market is projected to reach USD 706.50 Million in 2026. It is expected to continue growing at a CAGR of 6.25%, reaching USD 1.02 Billion by 2032.

Blood Lipid Test Kits: Executive Summary and Market Context

Blood lipid test kits support the measurement of indicators such as total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. They are used across clinical assessment, preventive care, chronic-disease management, pharmacies, and increasingly decentralized testing settings. Demand is shaped by the global burden of cardiovascular disease, wider screening initiatives, patient interest in self-monitoring, and the need for convenient, reliable results.

The category includes professional-use systems and consumer-oriented products, with meaningful differences in sample collection, analytical method, connectivity, interpretation, and regulatory oversight. Product value therefore depends not only on analytical performance but also on usability, workflow integration, quality assurance, and the clarity of information provided to patients and healthcare professionals.

Decentralized Care and Consumer Monitoring Are Reshaping Lipid Testing

The landscape is shifting from testing concentrated in hospitals and laboratories toward a more distributed model involving primary-care practices, community pharmacies, occupational-health programs, and home settings. This transition is supported by compact instruments, simplified sample handling, digital result transmission, and care pathways that use testing to improve follow-up and adherence.

At the same time, buyers are placing greater emphasis on evidence, interoperability, training, and total workflow cost. Regulatory expectations, reimbursement conditions, supply continuity, and the ability to connect results with electronic records remain important adoption considerations. Providers are also seeking solutions that reduce repeat visits while preserving appropriate clinical confirmation when results are abnormal or uncertain.

Artificial Intelligence Improves Interpretation, Triage, and Test-Kit Operations

Artificial intelligence can extend the usefulness of blood lipid test kits by identifying patterns across lipid results, patient history, and related risk factors. In clinical workflows, algorithms may support risk stratification, highlight potentially inconsistent readings, prioritize follow-up, and assist with personalized counseling. These capabilities are most valuable when they complement professional judgment rather than replace diagnostic confirmation.

AI is also relevant to operational performance. It can help detect instrument drift, monitor quality-control trends, anticipate consumable requirements, and identify barriers to patient engagement. Effective deployment requires representative validation, transparent outputs, privacy safeguards, cybersecurity controls, and clear accountability for clinical decisions. Poorly governed models may amplify disparities if training data do not reflect populations with different access patterns, comorbidities, or testing practices.

Regional Insights: Access, Regulation, and Care Delivery Define Adoption

North America benefits from established preventive-care infrastructure, strong interest in remote monitoring, and broad availability of digital health services, while adoption is influenced by reimbursement rules and regulatory requirements. Europe combines mature clinical systems with stringent quality, privacy, and conformity expectations; country-level differences in procurement and primary-care organization remain significant.

Asia-Pacific presents diverse conditions, ranging from advanced urban healthcare networks to settings where affordability, distribution, and workforce capacity are decisive. Latin America is shaped by uneven access, expanding private diagnostics, and the need for solutions suited to decentralized and resource-constrained care. In the Middle East, investment in modern healthcare infrastructure and chronic-disease programs supports demand, although procurement and localization requirements vary. Africa has substantial unmet screening needs, with deployment depending on affordability, reliable supply chains, power resilience, training, and integration with public-health programs.

Group Insights: Economic and Institutional Blocs Create Different Buying Priorities

ASEAN markets generally emphasize affordability, portability, workforce efficiency, and solutions that can operate across varied healthcare infrastructures. BRICS economies reflect a broad mix of public and private delivery models, with priorities spanning domestic production, access expansion, chronic-disease screening, and technology adaptation. The European Union places strong weight on regulatory compliance, data governance, clinical evidence, and cross-border quality consistency.

G7 settings tend to prioritize analytical reliability, interoperability, patient experience, and integration with established preventive-care pathways. GCC countries often focus on modernizing diagnostics, improving chronic-disease management, and deploying connected solutions within well-resourced health systems. NATO members represent diverse healthcare environments, but procurement resilience, clinical readiness, cybersecurity, and continuity of medical supply are recurring strategic considerations.

Country Insights: National Care Models Determine Deployment Priorities

Australia and Canada are positioned to benefit from decentralized testing where it supports primary care, rural access, and coordinated chronic-disease management. Brazil and Mexico face strong needs for accessible screening across unequal care networks, making affordability, distribution, and simplified workflows important. China and India combine large patient populations with varied regional infrastructure, creating demand for scalable solutions, local support, and integration with expanding diagnostic capacity.

France, Germany, Italy, Spain, and the United Kingdom are influenced by structured healthcare systems, evidence requirements, and efforts to strengthen prevention and community-based care. Japan and South Korea emphasize quality, aging-population needs, workflow efficiency, and technology-enabled monitoring. Russia’s deployment environment is shaped by healthcare access differences, procurement conditions, and supply resilience. In the United States, adoption is supported by preventive-care activity and digital health integration, while payment policy, regulatory compliance, and the division between screening and clinical diagnosis remain central considerations.

Action Priorities: Build Trust, Interoperability, and Access Into the Product Strategy

Industry leaders should prioritize validated analytical performance, transparent instructions, robust quality controls, and clear escalation pathways for results requiring professional confirmation. Products should be designed around the realities of intended users, including sample collection, literacy, language, accessibility, storage, power availability, and the need for repeat testing.

Interoperability should be treated as a core feature rather than an add-on. Secure connectivity with clinical records, pharmacy systems, telehealth platforms, and population-health tools can improve continuity of care. Organizations should also segment regional strategies by regulatory pathway, reimbursement environment, infrastructure, and workforce capability; establish resilient supply and service networks; and use AI only with documented validation, monitoring, privacy protection, and human oversight.

Research Methodology: Evidence-Based Assessment of Product and Care-Delivery Dynamics

This executive summary uses a structured secondary-research framework focused on the role of blood lipid test kits in clinical, community, pharmacy, and home-testing contexts. The assessment considers publicly available health-system information, clinical and regulatory literature, diagnostic-practice evidence, technology documentation, and regional care-delivery characteristics. Findings are synthesized thematically rather than expressed as market estimates, shares, or forecasts.

The analysis compares adoption conditions across the required regions, country groups, and countries using consistent dimensions: disease-prevention priorities, testing access, decentralization, regulatory expectations, digital integration, affordability, infrastructure, and implementation risk. Because product performance and clinical appropriateness depend on intended use, professional confirmation and local regulatory requirements remain essential when interpreting any individual test result.

Conclusion: Reliable, Connected Testing Can Strengthen Cardiovascular Prevention

Blood lipid test kits are increasingly relevant to preventive care and chronic-disease management as health systems seek convenient testing outside traditional laboratories. The strongest opportunities are associated with products that combine dependable measurement, simple workflows, clear interpretation, secure connectivity, and practical support for follow-up care.

Success will vary by geography and institutional group. Leaders that align product design with local infrastructure, regulatory expectations, reimbursement realities, and clinical workflows will be better positioned to expand responsible access. Sustained progress will depend on evidence-led innovation, equitable deployment, resilient operations, and careful use of AI under strong clinical and data-governance standards.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Lipid Test Kits Market, by Product Type
7.1. Introduction
7.2. Instruments
7.3. Reagents & Consumables
7.3.1. Kits
7.3.2. Strips
8. Blood Lipid Test Kits Market, by Test Type
8.1. Introduction
8.2. Automated Analyzers
8.3. Point Of Care Testing
9. Blood Lipid Test Kits Market, by Technology
9.1. Introduction
9.2. Dry Chemistry
9.3. Liquid Reagents
10. Blood Lipid Test Kits Market, by End User
10.1. Introduction
10.2. Clinical Laboratories
10.3. Home Care Settings
10.4. Hospitals And Clinics
10.5. Research Institutes
11. Blood Lipid Test Kits Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Blood Lipid Test Kits Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Blood Lipid Test Kits Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Blood Lipid Test Kits Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Alfresa Holdings Corporation
16.3. ARKRAY, Inc.
16.4. Asahi Kasei Corporation
16.5. Beckman Coulter, Inc.
16.6. bioMérieux SA
16.7. Daiichi Sankyo Company, Limited
16.8. Denka Seiken Co., Ltd.
16.9. Eiken Chemical Co., Ltd.
16.10. F. Hoffmann-La Roche AG
16.11. Fujifilm Wako Shibayagi Corporation
16.12. Horiba, Ltd.
16.13. Kyowa Medex Co., Ltd.
16.14. Mitsubishi Chemical Medience Corporation
16.15. Nitto Boseki Co., Ltd.
16.16. Ortho Clinical Diagnostics
16.17. Randox Laboratories Ltd.
16.18. Sekisui Medical Co., Ltd.
16.19. Shino-Test Corporation
16.20. Siemens Healthineers AG
16.21. SRL, Inc.
16.22. Sysmex Corporation
16.23. Thermo Fisher Scientific Inc.
16.24. Toyobo Co., Ltd.
16.25. Wako Pure Chemical Industries, Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Blood Lipid Test Kits Market, Years Considered for the Study
FIGURE 2. Global Blood Lipid Test Kits Market, Research Design
FIGURE 3. Global Blood Lipid Test Kits Market, Research Framework
FIGURE 4. Global Blood Lipid Test Kits Market, Data Triangulation
FIGURE 5. Global Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Blood Lipid Test Kits Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Blood Lipid Test Kits Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Blood Lipid Test Kits Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 9. Global Blood Lipid Test Kits Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Blood Lipid Test Kits Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Blood Lipid Test Kits Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Blood Lipid Test Kits Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Blood Lipid Test Kits Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Blood Lipid Test Kits Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Blood Lipid Test Kits Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Blood Lipid Test Kits Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Blood Lipid Test Kits Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Blood Lipid Test Kits Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Blood Lipid Test Kits Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Blood Lipid Test Kits Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Blood Lipid Test Kits Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Blood Lipid Test Kits Market Segmentation & Coverage
TABLE 2. Global Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 3. Global Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reagents & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reagents & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reagents & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Strips Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Strips Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Strips Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 17. Global Automated Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Automated Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Automated Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Point Of Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Point Of Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Point Of Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 24. Global Dry Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Dry Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Dry Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Liquid Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Liquid Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Liquid Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 31. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 44. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 58. North America Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. North America Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 60. North America Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 61. North America Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 62. North America Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 63. North America Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. North America Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. Latin America Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Latin America Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 67. Latin America Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 68. Latin America Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 69. Latin America Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 70. Latin America Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Latin America Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Europe Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Europe Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. Europe Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 75. Europe Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 76. Europe Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 77. Europe Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Europe Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Middle East Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Middle East Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Middle East Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 82. Middle East Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 83. Middle East Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 84. Middle East Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Middle East Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Africa Blood Lipid Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Africa Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. Africa Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 89. Africa Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 90. Africa Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 91. Africa Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Africa Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Global Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. ASEAN Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. ASEAN Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. ASEAN Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 97. ASEAN Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 98. ASEAN Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 99. ASEAN Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. ASEAN Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. GCC Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. GCC Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 103. GCC Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 104. GCC Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 105. GCC Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 106. GCC Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. GCC Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. European Union Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. European Union Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. European Union Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 111. European Union Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 112. European Union Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 113. European Union Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. European Union Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. BRICS Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. BRICS Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. BRICS Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 118. BRICS Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 119. BRICS Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 120. BRICS Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. BRICS Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. G7 Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. G7 Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. G7 Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 125. G7 Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 126. G7 Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. G7 Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. G7 Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. NATO Blood Lipid Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. NATO Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. NATO Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 132. NATO Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 133. NATO Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 134. NATO Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. NATO Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Global Blood Lipid Test Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. United States Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 138. United States Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. United States Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 140. United States Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 141. United States Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 142. United States Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. United States Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. Canada Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 145. Canada Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. Canada Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 147. Canada Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 148. Canada Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 149. Canada Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Canada Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. Mexico Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 152. Mexico Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. Mexico Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 154. Mexico Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 155. Mexico Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. Mexico Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Mexico Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Brazil Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 159. Brazil Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. Brazil Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 161. Brazil Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 162. Brazil Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 163. Brazil Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Brazil Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. United Kingdom Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 166. United Kingdom Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. United Kingdom Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 168. United Kingdom Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 169. United Kingdom Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 170. United Kingdom Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. United Kingdom Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Germany Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 173. Germany Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Germany Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 175. Germany Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 176. Germany Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. Germany Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Germany Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. France Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 180. France Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. France Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 182. France Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 183. France Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. France Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. France Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. Russia Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 187. Russia Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. Russia Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 189. Russia Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 190. Russia Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 191. Russia Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Russia Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. Italy Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 194. Italy Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. Italy Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 196. Italy Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 197. Italy Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 198. Italy Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Italy Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Spain Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 201. Spain Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Spain Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 203. Spain Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 204. Spain Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 205. Spain Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Spain Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. China Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 208. China Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. China Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 210. China Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 211. China Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 212. China Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. China Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. India Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 215. India Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. India Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 217. India Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 218. India Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 219. India Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. India Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Japan Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 222. Japan Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Japan Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 224. Japan Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 225. Japan Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Japan Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Japan Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Australia Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 229. Australia Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Australia Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 231. Australia Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 232. Australia Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. Australia Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Australia Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. South Korea Blood Lipid Test Kits Market Size, 2017-2032 (USD Million)
TABLE 236. South Korea Blood Lipid Test Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. South Korea Blood Lipid Test Kits Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 238. South Korea Blood Lipid Test Kits Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 239. South Korea Blood Lipid Test Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 240. South Korea Blood Lipid Test Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. South Korea Blood Lipid Test Kits Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. Global Blood Lipid Test Kits Market Share, by Key Player, 2025
TABLE 243. Global Blood Lipid Test Kits Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alfresa Holdings Corporation
  • ARKRAY, Inc.
  • Asahi Kasei Corporation
  • Beckman Coulter, Inc.
  • bioMérieux SA
  • Daiichi Sankyo Company, Limited
  • Denka Seiken Co., Ltd.
  • Eiken Chemical Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Fujifilm Wako Shibayagi Corporation
  • Horiba, Ltd.
  • Kyowa Medex Co., Ltd.
  • Mitsubishi Chemical Medience Corporation
  • Nitto Boseki Co., Ltd.
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Sekisui Medical Co., Ltd.
  • Shino-Test Corporation
  • Siemens Healthineers AG
  • SRL, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • Wako Pure Chemical Industries, Ltd.

Related Topics

Related Reports

Point of Care Lipid Test Market Report 2026 - Product Image

Point of Care Lipid Test Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Point of Care Lipid Test Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034 - Product Image

Point of Care Lipid Test Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034

  • Report
  • 160 Pages
  • Global
From
2025 Global Forecast for Point-Of-Care (Poc) Lipid Test Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Point-Of-Care (Poc) Lipid Test Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Lipid Panel Testing Market Report 2026 - Product Image

Lipid Panel Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cholesterol Testing Market - Global Forecast 2026-2032 - Product Image

Cholesterol Testing Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.